Otto, Angela M. and Faderl, Michael and Schönenberger, Helmut (1991) Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines. Cancer research 51 (12), pp. 3217-3223.
Full text not available from this repository.
The Pt complex [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]diaqua-Pt(II) sulfate (meso-6-PtSO4) was designed with the concept of combining the cytotoxic cisplatin with an estrogen receptor (ER)-binding ligand for targeting to ER+ mammary tumor cells. This Pt complex selectively inhibits growth of ER+ mammary tumors in rodents. To study the cellular mechanisms of action, cultures of ...
Export bibliographical data
|Additional Information (public):||CAN 115:64205 1-6 Pharmacology 105856-32-4 Role: PRP (Properties) (antitumor effects of, mammary estrogen receptor binding in relation to)|
|Institutions:||Chemistry and Pharmacy > Institute of Pharmacy > Alumni or Retired Professors > Prof. Schönenberger|
|Keywords:||Receptors Role: BIOL (Biological study) (for estrogens, platinum complexes antitumor effects and binding to mammary) Neoplasm inhibitors (platinum complexes as, mammary estrogen receptor binding in relation to) Estrogens Role: BIOL (Biological study) (receptors for, platinum complexes antitumor effects and binding to mammary) Mammary gland (neoplasm, estrogen receptors of, platinum complexes cytotoxicity in relation to binding to) platinum complex antitumor mammary estrogen receptor|
|Dewey Decimal Classification:||500 Science > 540 Chemistry & allied sciences|
|Refereed:||Yes, this version has been refereed|
|Created at the University of Regensburg:||Yes|
|Deposited On:||12 Nov 2010 07:08|
|Last Modified:||12 Nov 2010 07:08|